Beyond Immune Balance: The Pivotal Role of Decidual Regulatory T Cells in Unexplained Recurrent Spontaneous Abortion

References

• Förster R, Davalos-Misslitz AC, Rot A. CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol. 2008;8(5):362–371. doi:10.1038/nri2297
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Mikami N, Wing JB, Tanaka A, Ichiyama K, Ohkura N. Regulatory T cells and human disease. Annu Rev Immunol. 2020;38:541–566. doi:10.1146/annurev-immunol-042718-041717
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008;133:775–787. doi:10.1016/j.cell.2008.05.009
   PubMed Web of Science ®Google Scholar
• Jiang Q, Yang G, Liu Q, Wang S, Cui D. Function and Role of Regulatory T Cells in Rheumatoid Arthritis. Front Immunol. 2021;12:626193. doi:10.3389/fimmu.2021.626193
   PubMedGoogle Scholar
• Turner JA, Stephen-Victor E, Wang S, et al.. Regulatory T Cell-Derived TGF-β1 controls multiple checkpoints governing allergy and autoimmunity. Immunity. 2020;53:1202–1214.e6. doi:10.1016/j.immuni.2020.10.002
   PubMed Web of Science ®Google Scholar
• Bettini M, Bettini ML. Function, Failure, and the Future Potential of Tregs in Type 1 Diabetes. Diabetes. 2021;70:1211–1219. doi:10.2337/dbi18-0058
   PubMed Web of Science ®Google Scholar
• Daenthanasanmak A, Iamsawat S, Chakraborty P, et al.. Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice. Blood. 2019;133:266–279. doi:10.1182/blood-2018-07-863233
   PubMed Web of Science ®Google Scholar
• Hu X, Zhu Q, Wang Y, et al.. Newly characterized decidual Tim-3+ Treg cells are abundant during early pregnancy and driven by IL-27 coordinately with Gal-9 from trophoblasts. Hum Reprod. 2020;35:2454–2466. doi:10.1093/humrep/deaa223
   PubMed Web of Science ®Google Scholar
• Krop J, Heidt S, Claas F, Eikmans M. Regulatory T Cells in Pregnancy: it Is Not All About FoxP3. Front Immunol. 2020;11:1182. doi:10.3389/fimmu.2020.01182
   PubMed Web of Science ®Google Scholar
• Robertson SA, Care AS, Moldenhauer LM. Regulatory T cells in embryo implantation and the immune response to pregnancy. J Clin Invest. 2018;128:4224–4235. doi:10.1172/JCI122182
   PubMed Web of Science ®Google Scholar
• Care AS, Bourque SL, Morton JS, Hjartarson EP, Robertson SA, Davidge ST. Reduction in regulatory T cells in early pregnancy causes uterine artery dysfunction in mice. Hypertension. 2018;72:177–187. doi:10.1161/HYPERTENSIONAHA.118.10858
   PubMed Web of Science ®Google Scholar
• Samstein RM, Josefowicz SZ, Arvey A, Treuting PM, Rudensky AY. Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell. 2012;150:29–38. doi:10.1016/j.cell.2012.05.031
   PubMed Web of Science ®Google Scholar
• Tamosiuniene R, Manouvakhova O, Mesange P, et al.. Dominant role for regulatory T cells in protecting females against pulmonary hypertension. Circ Res. 2018;122:1689–1702. doi:10.1161/CIRCRESAHA.117.312058
   PubMed Web of Science ®Google Scholar
• Sharma M, Schlegel MP, Afonso MS, et al.. Regulatory T cells license macrophage pro-resolving functions during atherosclerosis regression. Circ Res. 2020;127:335–353. doi:10.1161/CIRCRESAHA.119.316461
   PubMed Web of Science ®Google Scholar
• Williams PJ, Searle RF, Robson SC, Innes BA, Bulmer JN. Decidual leucocyte populations in early to late gestation normal human pregnancy. J Reprod Immunol. 2009;82:24–31. doi:10.1016/j.jri.2009.08.001
   PubMed Web of Science ®Google Scholar
• Mjösberg J, Berg G, Jenmalm MC, Ernerudh J. FOXP3+ regulatory T cells and T helper 1, T helper 2, and T helper 17 cells in human early pregnancy decidua. Biol Reprod. 2010;82:698–705. doi:10.1095/biolreprod.109.081208
   PubMed Web of Science ®Google Scholar
• Tilburgs T, Roelen DL, van der Mast BJ, et al.. Differential distribution of CD4(+)CD25(bright) and CD8(+)CD28(-) T-cells in decidua and maternal blood during human pregnancy. Placenta. 2006;27:S47–53. doi:10.1016/j.placenta.2005.11.008
   PubMed Web of Science ®Google Scholar
• Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004;22:531–562. doi:10.1146/annurev.immunol.21.120601.141122
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155:1151–1164. doi:10.4049/jimmunol.155.3.1151
   PubMed Web of Science ®Google Scholar
• Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057–1061. doi:10.1126/science.1079490
   PubMed Web of Science ®Google Scholar
• Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol. 2003;4:337–342. doi:10.1038/ni909
   PubMed Web of Science ®Google Scholar
• Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003;4:330–336. doi:10.1038/ni904
   PubMed Web of Science ®Google Scholar
• Zhang YH, Sun HX. Immune checkpoint molecules in pregnancy: focus on regulatory T cells. Eur J Immunol. 2020;50:160–169. doi:10.1002/eji.201948382
   PubMed Web of Science ®Google Scholar
• Miko E, Meggyes M, Doba K, Barakonyi A, Szereday L. Immune Checkpoint Molecules in Reproductive Immunology. Front Immunol. 2019;10:846. doi:10.3389/fimmu.2019.00846
   PubMed Web of Science ®Google Scholar
• Xu YY, Wang SC, Li DJ, Du MR. Co-signaling molecules in maternal-fetal immunity. Trends Mol Med. 2017;23:46–58. doi:10.1016/j.molmed.2016.11.001
   PubMed Web of Science ®Google Scholar
• Joller N, Kuchroo VK. Tim-3, Lag-3, and TIGIT. Curr Top Microbiol Immunol. 2017;410:127–156. doi:10.1007/82_2017_62
   PubMed Web of Science ®Google Scholar
• Wagner MI, Jöst M, Spratte J, et al.. Differentiation of ICOS+ and ICOS- recent thymic emigrant regulatory T cells (RTE T regs) during normal pregnancy, pre-eclampsia and HELLP syndrome. Clin Exp Immunol. 2016;183:129–142. doi:10.1111/cei.12693
   PubMed Web of Science ®Google Scholar
• Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril. 2020;113:533–535. doi:10.1016/j.fertnstert.2019.11.025
   PubMed Web of Science ®Google Scholar
• Dimitriadis E, Menkhorst E, Saito S, Kutteh WH, Brosens JJ. Recurrent pregnancy loss. Nat Rev Dis Primers. 2020;6:98. doi:10.1038/s41572-020-00228-z
   PubMed Web of Science ®Google Scholar
• Garrido-Gimenez C, Alijotas-Reig J. Recurrent miscarriage: causes, evaluation and management. Postgrad Med J. 2015;91:151–162. doi:10.1136/postgradmedj-2014-132672
   PubMed Web of Science ®Google Scholar
• Alves C, Jenkins SM, Rapp A. StatPearls. Treasure Island (FL): StatPearls; 2024.
   Google Scholar
• Daumová M, Hadravská Š, Putzová M. Spontaneous abortion in the first trimester of pregnancy. Cesk Patol. 2023;59(2):60–63.
   PubMedGoogle Scholar
• Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012;98:1103–1111. doi:10.1016/j.fertnstert.2012.06.048
   PubMed Web of Science ®Google Scholar
• Sun H, Mao J, Su X, Du Q. Impact of spontaneous abortion history and induced abortion history on perinatal outcomes of singleton pregnancies. BMC Public Health. 2023;23(1):2360. doi:10.1186/s12889-023-17264-5
   PubMed Web of Science ®Google Scholar
• de Ziegler D, Frydman RF. Recurrent pregnancy losses, a lasting cause of infertility. Fertil Steril. 2021;115(3):531–532. doi:10.1016/j.fertnstert.2020.12.004
   PubMed Web of Science ®Google Scholar
• Schatz F, Guzeloglu-Kayisli O, Arlier S, Kayisli UA, Lockwood CJ. The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding. Hum Reprod Update. 2016;22:497–515. doi:10.1093/humupd/dmw004
   PubMed Web of Science ®Google Scholar
• Du Y, Fang Q, Zheng SG. Regulatory T cells: concept, classification, phenotype, and biological characteristics. Adv Exp Med Biol. 2021;1278:1–31. doi:10.1007/978-981-15-6407-9_1
   PubMed Web of Science ®Google Scholar
• Josefowicz SZ, Niec RE, Kim HY, et al.. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature. 2012;482:395–399. doi:10.1038/nature10772
   PubMed Web of Science ®Google Scholar
• Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. 2012;30:531–564. doi:10.1146/annurev.immunol.25.022106.141623
   PubMed Web of Science ®Google Scholar
• Abbas AK, Benoist C, Bluestone JA, et al.. Regulatory T cells: recommendations to simplify the nomenclature. Nat Immunol. 2013;14:307–308. doi:10.1038/ni.2554
   PubMed Web of Science ®Google Scholar
• Smigiel KS, Srivastava S, Stolley JM, Campbell DJ. Regulatory T-cell homeostasis: steady-state maintenance and modulation during inflammation. Immunol Rev. 2014;259:40–59. doi:10.1111/imr.12170
   PubMed Web of Science ®Google Scholar
• Liston A, Gray DH. Homeostatic control of regulatory T cell diversity. Nat Rev Immunol. 2014;14:154–165. doi:10.1038/nri3605
   PubMed Web of Science ®Google Scholar
• Dias S, D’Amico A, Cretney E, et al.. Effector Regulatory T cell differentiation and immune homeostasis depend on the transcription factor Myb. Immunity. 2017;46:78–91. doi:10.1016/j.immuni.2016.12.017
   PubMed Web of Science ®Google Scholar
• Burzyn D, Benoist C, Mathis D. Regulatory T cells in nonlymphoid tissues. Nat Immunol. 2013;14:1007–1013. doi:10.1038/ni.2683
   PubMed Web of Science ®Google Scholar
• Miragaia RJ, Gomes T, Chomka A, et al.. Single-cell transcriptomics of regulatory T cells reveals trajectories of tissue adaptation. Immunity. 2019;50:493–504.e7. doi:10.1016/j.immuni.2019.01.001
   PubMed Web of Science ®Google Scholar
• Yu X, Harden K, Gonzalez LC, et al.. The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat Immunol. 2009;10:48–57. doi:10.1038/ni.1674
   PubMed Web of Science ®Google Scholar
• Brlić P K, Lenac Roviš T, Cinamon G, Tsukerman P, Mandelboim O, Jonjić S. Targeting PVR (CD155) and its receptors in anti-tumor therapy. Cell Mol Immunol. 2019;16:40–52. doi:10.1038/s41423-018-0168-y
   PubMed Web of Science ®Google Scholar
• Joller N, Lozano E, Burkett PR, et al.. Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses. Immunity. 2014;40:569–581. doi:10.1016/j.immuni.2014.02.012
   PubMed Web of Science ®Google Scholar
• Levine AG, Mendoza A, Hemmers S, et al.. Stability and function of regulatory T cells expressing the transcription factor T-bet. Nature. 2017;546:421–425. doi:10.1038/nature22360
   PubMed Web of Science ®Google Scholar
• Paust S, Lu L, McCarty N, Cantor H. Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc Natl Acad Sci USA. 2004;101:10398–10403. doi:10.1073/pnas.0403342101
   PubMed Web of Science ®Google Scholar
• Fallarino F, Grohmann U, Hwang KW, et al.. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol. 2003;4:1206–1212. doi:10.1038/ni1003
   PubMed Web of Science ®Google Scholar
• Tan CL, Kuchroo JR, Sage PT, et al.. PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance. J Exp Med. 2021;218:e20182232.
   PubMed Web of Science ®Google Scholar
• Maruhashi T, Sugiura D, Okazaki IM, et al.. Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunity. Immunity. 2022;55:912–924.e8. doi:10.1016/j.immuni.2022.03.013
   PubMed Web of Science ®Google Scholar
• Bodmer JL, Holler N, Reynard S, et al.. TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat Cell Biol. 2000;2:241–243. doi:10.1038/35008667
   PubMed Web of Science ®Google Scholar
• Ren X, Ye F, Jiang Z, Chu Y, Xiong S, Wang Y. Involvement of cellular death in TRAIL/DR5-dependent suppression induced by CD4(+)CD25(+) regulatory T cells. Cell Death Differ. 2007;14:2076–2084. doi:10.1038/sj.cdd.4402220
   PubMed Web of Science ®Google Scholar
• Śledzińska A, Vila de Mucha M, Bergerhoff K, et al.. Regulatory T Cells Restrain Interleukin-2- and Blimp-1-Dependent Acquisition of Cytotoxic Function by CD4(+) T Cells. Immunity. 2020;52:151–166.e6. doi:10.1016/j.immuni.2019.12.007
   PubMed Web of Science ®Google Scholar
• Sundström P, Stenstad H, Langenes V, et al.. Regulatory T cells from colon cancer patients inhibit effector T-cell migration through an adenosine-dependent mechanism. Cancer Immunol Res. 2016;4:183–193. doi:10.1158/2326-6066.CIR-15-0050
   PubMed Web of Science ®Google Scholar
• Klein M, Bopp T. Cyclic AMP represents a crucial component of treg cell-mediated immune regulation. Front Immunol. 2016;7:315. doi:10.3389/fimmu.2016.00315
   PubMed Web of Science ®Google Scholar
• Su W, Chen X, Zhu W, et al.. The cAMP-adenosine feedback loop maintains the suppressive function of regulatory T cells. J Immunol. 2019;203:1436–1446. doi:10.4049/jimmunol.1801306
   PubMed Web of Science ®Google Scholar
• Schneider E, Winzer R, Rissiek A, et al.. CD73-mediated adenosine production by CD8 T cell-derived extracellular vesicles constitutes an intrinsic mechanism of immune suppression. Nat Commun. 2021;12:5911. doi:10.1038/s41467-021-26134-w
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Ohnuma K, Furue MK. Pluripotent Stem Cell Heterogeneity. Adv Exp Med Biol. 2019;1123:71–94.
   PubMed Web of Science ®Google Scholar
• Zhao DM, Thornton AM, DiPaolo RJ, Shevach EM. Activated CD4+CD25+ T cells selectively kill B lymphocytes. Blood. 2006;107:3925–3932. doi:10.1182/blood-2005-11-4502
   PubMed Web of Science ®Google Scholar
• Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity. 2004;21:589–601. doi:10.1016/j.immuni.2004.09.002
   PubMed Web of Science ®Google Scholar
• Gondek DC, Devries V, Nowak EC, et al.. Transplantation survival is maintained by granzyme B+ regulatory cells and adaptive regulatory T cells. J Immunol. 2008;181:4752–4760. doi:10.4049/jimmunol.181.7.4752
   PubMed Web of Science ®Google Scholar
• Yano H, Andrews LP, Workman CJ, Vignali D. Intratumoral regulatory T cells: markers, subsets and their impact on anti-tumor immunity. Immunology. 2019;157:232–247. doi:10.1111/imm.13067
   PubMed Web of Science ®Google Scholar
• Inada K, Shima T, Ito M, Ushijima A, Saito S. Helios-positive functional regulatory T cells are decreased in decidua of miscarriage cases with normal fetal chromosomal content. J Reprod Immunol. 2015;107:10–19. doi:10.1016/j.jri.2014.09.053
   PubMed Web of Science ®Google Scholar
• Hsu P, Santner-Nanan B, Dahlstrom JE, et al.. Altered decidual DC-SIGN+ antigen-presenting cells and impaired regulatory T-cell induction in preeclampsia. Am J Pathol. 2012;181:2149–2160. doi:10.1016/j.ajpath.2012.08.032
   PubMed Web of Science ®Google Scholar
• Arruvito L, Sanz M, Banham AH, Fainboim L. Expansion of CD4+CD25+and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J Immunol. 2007;178:2572–2578. doi:10.4049/jimmunol.178.4.2572
   PubMed Web of Science ®Google Scholar
• Lee SJ, Song L, Yang MC, et al.. Local administration of granulocyte macrophage colony-stimulating factor induces local accumulation of dendritic cells and antigen-specific CD8+ T cells and enhances dendritic cell cross-presentation. Vaccine. 2015;33:1549–1555. doi:10.1016/j.vaccine.2015.02.019
   PubMed Web of Science ®Google Scholar
• Tao Y, Li YH, Zhang D, et al.. Decidual CXCR4(+) CD56(bright) NK cells as a novel NK subset in maternal-foetal immune tolerance to alleviate early pregnancy failure. Clin Transl Med. 2021;11:e540.
   PubMed Web of Science ®Google Scholar
• Li Z, Liang X, Chen X, et al.. The role of thymus- and extrathymus-derived regulatory T cells in maternal-fetal tolerance. Front Immunol. 2023;14:1109352. doi:10.3389/fimmu.2023.1109352
   PubMed Web of Science ®Google Scholar
• Yasuda I, Shima T, Moriya T, et al.. Dynamic changes in the phenotype of dendritic cells in the uterus and uterine draining lymph nodes after coitus. Front Immunol. 2020;11:557720. doi:10.3389/fimmu.2020.557720
   PubMed Web of Science ®Google Scholar
• Kallikourdis M, Betz AG. Periodic accumulation of regulatory T cells in the uterus: preparation for the implantation of a semi-allogeneic fetus. PLoS One. 2007;2:e382.
   PubMed Web of Science ®Google Scholar
• Shima T, Sasaki Y, Itoh M, et al.. Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice. J Reprod Immunol. 2010;85:121–129. doi:10.1016/j.jri.2010.02.006
   PubMed Web of Science ®Google Scholar
• Moldenhauer LM, Diener KR, Hayball JD, Robertson SA. An immunogenic phenotype in paternal antigen-specific CD8(+) T cells at embryo implantation elicits later fetal loss in mice. Immunol Cell Biol. 2017;95:705–715. doi:10.1038/icb.2017.41
   PubMed Web of Science ®Google Scholar
• Chaturvedi V, Ertelt JM, Jiang TT, et al.. CXCR3 blockade protects against Listeria monocytogenes infection-induced fetal wastage. J Clin Invest. 2015;125:1713–1725. doi:10.1172/JCI78578
   PubMed Web of Science ®Google Scholar
• Li L, Tu J, Jiang Y, Zhou J, Schust DJ. Regulatory T cells decrease invariant natural killer T cell-mediated pregnancy loss in mice. Mucosal Immunol. 2017;10:613–623. doi:10.1038/mi.2016.84
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu Z, Tian M, et al.. The altered PD-1/PD-L1 pathway delivers the ‘one-two punch’ effects to promote the Treg/Th17 imbalance in pre-eclampsia. Cell Mol Immunol. 2018;15:710–723. doi:10.1038/cmi.2017.70
   PubMed Web of Science ®Google Scholar
• Erlebacher A. Immunology of the maternal-fetal interface. Annu Rev Immunol. 2013;31:387–411. doi:10.1146/annurev-immunol-032712-100003
   PubMed Web of Science ®Google Scholar
• Jiang X, Wang H. Macrophage subsets at the maternal-fetal interface. Cell Mol Immunol. 2020;17:889–891. doi:10.1038/s41423-020-0435-6
   PubMed Web of Science ®Google Scholar
• Wang F, Qualls AE, Marques-Fernandez L, Colucci F. Biology and pathology of the uterine microenvironment and its natural killer cells. Cell Mol Immunol. 2021;18:2101–2113. doi:10.1038/s41423-021-00739-z
   PubMed Web of Science ®Google Scholar
• Guerin LR, Moldenhauer LM, Prins JR, Bromfield JJ, Hayball JD, Robertson SA. Seminal fluid regulates accumulation of FOXP3+ regulatory T cells in the preimplantation mouse uterus through expanding the FOXP3+ cell pool and CCL19-mediated recruitment. Biol Reprod. 2011;85:397–408. doi:10.1095/biolreprod.110.088591
   PubMed Web of Science ®Google Scholar
• Shima T, Nakashima A, Yasuda I, et al.. Uterine CD11c+ cells induce the development of paternal antigen-specific Tregs via seminal plasma priming. J Reprod Immunol. 2020;141:103165. doi:10.1016/j.jri.2020.103165
   PubMed Web of Science ®Google Scholar
• Blois SM, Ilarregui JM, Tometten M, et al.. A pivotal role for galectin-1 in fetomaternal tolerance. Nat Med. 2007;13:1450–1457. doi:10.1038/nm1680
   PubMed Web of Science ®Google Scholar
• Vacca P, Cantoni C, Vitale M, et al.. Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression. Proc Natl Acad Sci U S A. 2010;107:11918–11923. doi:10.1073/pnas.1001749107
   PubMed Web of Science ®Google Scholar
• Munn DH, Zhou M, Attwood JT, et al.. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science. 1998;281:1191–1193. doi:10.1126/science.281.5380.1191
   PubMed Web of Science ®Google Scholar
• Zhang J, Dunk C, Croy AB, Lye SJ. To serve and to protect: the role of decidual innate immune cells on human pregnancy. Cell Tissue Res. 2016;363:249–265. doi:10.1007/s00441-015-2315-4
   PubMed Web of Science ®Google Scholar
• Perchellet AL, Jasti S, Petroff MG. Maternal CD4⁺ and CD8⁺ T cell tolerance towards a fetal minor histocompatibility antigen in T cell receptor transgenic mice. Biol Reprod. 2013;89:102. doi:10.1095/biolreprod.113.110445
   PubMed Web of Science ®Google Scholar
• Wang S, Qian J, Sun F, et al.. Bidirectional regulation between 1st trimester HTR8/SVneo trophoblast cells and in vitro differentiated Th17/Treg cells suggest a fetal-maternal regulatory loop in human pregnancy. Am J Reprod Immunol. 2019;81:e13106. doi:10.1111/aji.13106
   PubMed Web of Science ®Google Scholar
• Fu YY, Ren CE, Qiao PY, Meng YH. Uterine natural killer cells and recurrent spontaneous abortion. Am J Reprod Immunol. 2021;86:e13433.
   PubMed Web of Science ®Google Scholar
• Díaz-Hernández I, Alecsandru D, García-Velasco JA, Domínguez F. Uterine natural killer cells: from foe to friend in reproduction. Hum Reprod Update. 2021;27:720–746. doi:10.1093/humupd/dmaa062
   PubMed Web of Science ®Google Scholar
• Heikkinen J, Möttönen M, Alanen A, Lassila O. Phenotypic characterization of regulatory T cells in the human decidua. Clin Exp Immunol. 2004;136:373–378. doi:10.1111/j.1365-2249.2004.02441.x
   PubMed Web of Science ®Google Scholar
• Dimova T, Nagaeva O, Stenqvist AC, et al.. Maternal Foxp3 expressing CD4+ CD25+ and CD4+ CD25- regulatory T-cell populations are enriched in human early normal pregnancy decidua: a phenotypic study of paired decidual and peripheral blood samples. Am J Reprod Immunol. 2011;66(1):44–56. doi:10.1111/j.1600-0897.2011.01046.x
   PubMedGoogle Scholar
• Salvany-Celades M, van der Zwan A, Benner M, et al.. Tilburgs T: three types of functional regulatory T Cells Control T cell responses at the human maternal-fetal interface. Cell Rep. 2019;27:2537–2547.e5. doi:10.1016/j.celrep.2019.04.109
   PubMed Web of Science ®Google Scholar
• Zare M, Namavar Jahromi B, Gharesi-Fard B. Analysis of the frequencies and functions of CD4(+)CD25(+)CD127(low/neg), CD4(+)HLA-G(+), and CD8(+)HLA-G(+) regulatory T cells in pre-eclampsia. J Reprod Immunol. 2019;133:43–51. doi:10.1016/j.jri.2019.06.002
   PubMed Web of Science ®Google Scholar
• Hsu P, Santner-Nanan B, Joung S, Peek MJ, Nanan R. Expansion of CD4(+) HLA-G(+) T Cell in human pregnancy is impaired in pre-eclampsia. Am J Reprod Immunol. 2014;71:217–228. doi:10.1111/aji.12195
   PubMed Web of Science ®Google Scholar
• Huang YH, Zozulya AL, Weidenfeller C, Schwab N, Wiendl H. T cell suppression by naturally occurring HLA-G-expressing regulatory CD4+ T cells is IL-10-dependent and reversible. J Leukoc Biol. 2009;86:273–281. doi:10.1189/jlb.1008649
   PubMed Web of Science ®Google Scholar
• Levings MK, Bacchetta R, Schulz U, Roncarolo MG. The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells. Int Arch Allergy Immunol. 2002;129:263–276. doi:10.1159/000067596
   PubMed Web of Science ®Google Scholar
• Sanjabi S, Oh SA, Li MO. Regulation of the immune response by TGF-β: from conception to autoimmunity and infection. Cold Spring Harb Perspect Biol. 2017;9:a022236. doi:10.1101/cshperspect.a022236
   PubMed Web of Science ®Google Scholar
• Zhang J, Dunk CE, Shynlova O, Caniggia I, Lye SJ. TGFb1 suppresses the activation of distinct dNK subpopulations in preeclampsia. EBioMedicine. 2019;39:531–539. doi:10.1016/j.ebiom.2018.12.015
   PubMed Web of Science ®Google Scholar
• Häringer B, Lozza L, Steckel B, Geginat J. Identification and characterization of IL-10/IFN-gamma-producing effector-like T cells with regulatory function in human blood. J Exp Med. 2009;206:1009–1017.
   PubMed Web of Science ®Google Scholar
• Akdis M, Verhagen J, Taylor A, et al.. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med. 2004;199:1567–1575. doi:10.1084/jem.20032058
   PubMed Web of Science ®Google Scholar
• White AM, Wraith DC. Tr1-Like T cells - an enigmatic regulatory T cell lineage. Front Immunol. 2016;7:355. doi:10.3389/fimmu.2016.00355
   PubMed Web of Science ®Google Scholar
• Niedzielska M, Israelsson E, Angermann B, et al.. Differential gene expression in human tissue resident regulatory T cells from lung, colon, and blood. Oncotarget. 2018;9:36166–36184. doi:10.18632/oncotarget.26322
   PubMedGoogle Scholar
• Weiner HL. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev. 2001;182:207–214. doi:10.1034/j.1600-065X.2001.1820117.x
   PubMed Web of Science ®Google Scholar
• Elkord E, Abd Al Samid M, Chaudhary B. Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP. Oncotarget. 2015;6:20026–20036.
   PubMed Web of Science ®Google Scholar
• Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol. 2004;5:266–271. doi:10.1038/ni1037
   PubMed Web of Science ®Google Scholar
• Woidacki K, Meyer N, Schumacher A, Goldschmidt A, Maurer M, Zenclussen AC. Transfer of regulatory T cells into abortion-prone mice promotes the expansion of uterine mast cells and normalizes early pregnancy angiogenesis. Sci Rep. 2015;5:13938. doi:10.1038/srep13938
   PubMed Web of Science ®Google Scholar
• Keller CC, Eikmans M, van der Hoorn MP, Lashley L. Recurrent miscarriages and the association with regulatory T cells; A systematic review. J Reprod Immunol. 2020;139:103105. doi:10.1016/j.jri.2020.103105
   PubMed Web of Science ®Google Scholar
• Banerjee P, Jana SK, Pasricha P, Ghosh S, Chakravarty B, Chaudhury K. Proinflammatory cytokines induced altered expression of cyclooxygenase-2 gene results in unreceptive endometrium in women with idiopathic recurrent spontaneous miscarriage. Fertil Steril. 2013;99:179–187.e2. doi:10.1016/j.fertnstert.2012.08.034
   PubMed Web of Science ®Google Scholar
• Yang X, Tian Y, Zheng L, Luu T, Kwak-Kim J. The Update Immune-Regulatory Role of Pro- and Anti-Inflammatory Cytokines in Recurrent Pregnancy Losses. Int J Mol Sci. 2022;24:132. doi:10.3390/ijms24010132
   PubMed Web of Science ®Google Scholar
• Kwak-Kim J, Bao S, Lee SK, Kim JW, Gilman-Sachs A. Immunological modes of pregnancy loss: inflammation, immune effectors, and stress. Am J Reprod Immunol. 2014;72:129–140. doi:10.1111/aji.12234
   PubMed Web of Science ®Google Scholar
• Lissauer D, Goodyear O, Khanum R, Moss PA, Kilby MD. Profile of maternal CD4 T-cell effector function during normal pregnancy and in women with a history of recurrent miscarriage. Clin Sci (Lond). 2014;126:347–354. doi:10.1042/CS20130247
   PubMed Web of Science ®Google Scholar
• Lédée N, Munaut C, Aubert J, et al.. Specific and extensive endometrial deregulation is present before conception in IVF/ICSI repeated implantation failures (IF) or recurrent miscarriages. J Pathol. 2011;225:554–564. doi:10.1002/path.2948
   PubMed Web of Science ®Google Scholar
• Zhao X, Jiang Y, Wang L, Li Z, Li Q, Feng X. Advances in understanding the immune imbalance between T-Lymphocyte Subsets and NK cells in recurrent spontaneous abortion. Geburtshilfe Frauenheilkd. 2018;78(7):677–683. doi:10.1055/a-0634-1813
   PubMed Web of Science ®Google Scholar
• Cubro H, Kashyap S, Nath MC, Ackerman AW, Garovic VD. The role of interleukin-10 in the pathophysiology of preeclampsia. Curr Hypertens Rep. 2018;20:36. doi:10.1007/s11906-018-0833-7
   PubMed Web of Science ®Google Scholar
• Kedzierska AE, Lorek D, Slawek A, Chelmonska-Soyta A. Tregitopes regulate the tolerogenic immune response and decrease the foetal death rate in abortion-prone mouse matings. Sci Rep. 2020;10:10531. doi:10.1038/s41598-020-66957-z
   PubMed Web of Science ®Google Scholar
• Granne I, Shen M, Rodriguez-Caro H, et al.. Characterisation of peri-implantation endometrial Treg and identification of an altered phenotype in recurrent pregnancy loss. Mucosal Immunol. 2022;15:120–129. doi:10.1038/s41385-021-00451-1
   PubMed Web of Science ®Google Scholar
• Yang H, Qiu L, Chen G, Ye Z, C L, Lin Q. Proportional change of CD4+CD25+ regulatory T cells in decidua and peripheral blood in unexplained recurrent spontaneous abortion patients. Fertil Steril. 2008;89:656–661. doi:10.1016/j.fertnstert.2007.03.037
   PubMed Web of Science ®Google Scholar
• Jin LP, Chen QY, Zhang T, Guo PF, Li DJ. The CD4+CD25 bright regulatory T cells and CTLA-4 expression in peripheral and decidual lymphocytes are down-regulated in human miscarriage. Clin Immunol. 2009;133:402–410. doi:10.1016/j.clim.2009.08.009
   PubMed Web of Science ®Google Scholar
• Inada K, Shima T, Nakashima A, Aoki K, Ito M, Saito S. Characterization of regulatory T cells in decidua of miscarriage cases with abnormal or normal fetal chromosomal content. J Reprod Immunol. 2013;97:104–111. doi:10.1016/j.jri.2012.12.001
   PubMed Web of Science ®Google Scholar
• Sasaki Y, Sakai M, Miyazaki S, Higuma S, Shiozaki A, Saito S. Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod. 2004;10:347–353. doi:10.1093/molehr/gah044
   PubMed Web of Science ®Google Scholar
• Wang WJ, Hao CF, Yi-Lin Y, Bao GJ, Qiu SH, Lin LH. QD: increased prevalence of T helper 17 (Th17) cells in peripheral blood and decidua in unexplained recurrent spontaneous abortion patients. J Reprod Immunol. 2010;84:164–170. doi:10.1016/j.jri.2009.12.003
   PubMed Web of Science ®Google Scholar
• Robertson SA, Sharkey DJ. Seminal fluid and fertility in women. Fertil Steril. 2016;106:511–519. doi:10.1016/j.fertnstert.2016.07.1101
   PubMed Web of Science ®Google Scholar
• Omenetti S, Pizarro TT. The Treg/Th17 Axis: a dynamic balance regulated by the gut microbiome. Front Immunol. 2015;6:639. doi:10.3389/fimmu.2015.00639
   PubMed Web of Science ®Google Scholar
• Sadlon T, Brown CY, Bandara V, et al.. Unravelling the molecular basis for regulatory T-cell plasticity and loss of function in disease. Clin Transl Immunology. 2018;7:e1011.
   PubMed Web of Science ®Google Scholar
• Schjenken JE, Zhang B, Chan HY, Sharkey DJ, Fullston T, Robertson SA. mi RNA Regulation of Immune Tolerance in Early Pregnancy. Am J Reprod Immunol. 2016;75:272–280. doi:10.1111/aji.12490
   PubMed Web of Science ®Google Scholar
• Hori S. Lineage stability and phenotypic plasticity of Foxp3⁺ regulatory T cells. Immunol Rev. 2014;259:159–172. doi:10.1111/imr.12175
   PubMed Web of Science ®Google Scholar
• Liu C, Wang XZ, Sun XB. Assessment of sperm antigen specific T regulatory cells in women with recurrent miscarriage. Early Hum Dev. 2013;89:95–100. doi:10.1016/j.earlhumdev.2012.08.003
   PubMed Web of Science ®Google Scholar
• Bettelli E, Carrier Y, Gao W, et al.. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441:235–238. doi:10.1038/nature04753
   PubMed Web of Science ®Google Scholar
• Zhao J, Zhao J, Perlman S. Differential effects of IL-12 on Tregs and non-Treg T cells: roles of IFN-γ, IL-2 and IL-2R. PLoS One. 2012;7:e46241.
   PubMed Web of Science ®Google Scholar
• Prins JR, Zhang B, Schjenken JE, Guerin LR, Barry SC, Robertson SA. Unstable Foxp3+ regulatory T cells and altered dendritic cells are associated with lipopolysaccharide-induced fetal loss in pregnant interleukin 10-deficient mice. Biol Reprod. 2015;93:95. doi:10.1095/biolreprod.115.128694
   PubMed Web of Science ®Google Scholar
• Rowe JH, Ertelt JM, Aguilera MN, Farrar MA, Way SS. Foxp3(+) regulatory T cell expansion required for sustaining pregnancy compromises host defense against prenatal bacterial pathogens. Cell Host Microbe. 2011;10:54–64. doi:10.1016/j.chom.2011.06.005
   PubMed Web of Science ®Google Scholar
• Robertson SA. Immune regulation of conception and embryo implantation-all about quality control. J Reprod Immunol. 2010;85:51–57. doi:10.1016/j.jri.2010.01.008
   PubMed Web of Science ®Google Scholar
• Mazziotta C, Pellielo G, Tognon M, Martini F, Rotondo JC. Significantly low levels of igg antibodies against oncogenic Merkel cell polyomavirus in sera from females affected by spontaneous abortion. Front Microbiol. 2021;12:789991. doi:10.3389/fmicb.2021.789991
   PubMed Web of Science ®Google Scholar
• D’Addio F, Riella LV, Mfarrej BG, et al.. The link between the PDL1 costimulatory pathway and Th17 in fetomaternal tolerance. J Immunol. 2011;187:4530–4541. doi:10.4049/jimmunol.1002031
   PubMed Web of Science ®Google Scholar
• Chang J-H, Xiao Y, Hu H, et al.. Ubc13 maintains the suppressive function of regulatory T cells and prevents their conversion into effector-like T cells. Nat Immunol. 2012;13(5):481–490. doi:10.1038/ni.2267
   PubMed Web of Science ®Google Scholar
• Steinborn A, Schmitt E, Kisielewicz A, et al.. Pregnancy-associated diseases are characterized by the composition of the systemic regulatory T cell (Treg) pool with distinct subsets of Tregs. Clin Exp Immunol. 2012;167:84–98. doi:10.1111/j.1365-2249.2011.04493.x
   PubMed Web of Science ®Google Scholar
• Bluestone JA, Trotta E, Xu D. The therapeutic potential of regulatory T cells for the treatment of autoimmune disease. Expert Opin Ther Targets. 2015;19:1091–1103. doi:10.1517/14728222.2015.1037282
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wang HY, Marzec M, Raghunath PN, Nagasawa T, Wasik MA. STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes. Proc Natl Acad Sci U S A. 2005;102:6948–6953. doi:10.1073/pnas.0501959102
   PubMed Web of Science ®Google Scholar
• Hodge DR, Cho E, Copeland TD, et al.. IL-6 enhances the nuclear translocation of DNA cytosine-5-methyltransferase 1 (DNMT1) via phosphorylation of the nuclear localization sequence by the AKT kinase. Cancer Genomics Proteomics. 2007;4:387–398.
   PubMedGoogle Scholar
• Kimura A, Kishimoto T. IL-6: regulator of Treg/Th17 balance. Eur J Immunol. 2010;40:1830–1835. doi:10.1002/eji.201040391
   PubMed Web of Science ®Google Scholar
• Raffin C, Vo LT, Bluestone JA. T(reg) cell-based therapies: challenges and perspectives. Nat Rev Immunol. 2020;20:158–172. doi:10.1038/s41577-019-0232-6
   PubMed Web of Science ®Google Scholar
• Nishimoto N, Yoshizaki K, Miyasaka N, et al.. Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum. 2004;50:1761–1769. doi:10.1002/art.20303
   PubMed Web of Science ®Google Scholar
• Ito H, Takazoe M, Fukuda Y, et al.. A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn’s disease. Gastroenterology. 2004;126:989–996. doi:10.1053/j.gastro.2004.01.012
   PubMed Web of Science ®Google Scholar
• Illei GG, Shirota Y, Yarboro CH, et al.. Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study. Arthritis Rheum. 2010;62:542–552. doi:10.1002/art.27221
   PubMed Web of Science ®Google Scholar
• Abbas AK, Trotta E, Simeonov D, Marson A, Bluestone JA. Revisiting IL-2: biology and therapeutic prospects. Sci Immunol. 2018;3:eaat1482. doi:10.1126/sciimmunol.aat1482
   PubMed Web of Science ®Google Scholar
• Barron L, Dooms H, Hoyer KK, et al.. Cutting edge: mechanisms of IL-2-dependent maintenance of functional regulatory T cells. J Immunol. 2010;185:6426–6430. doi:10.4049/jimmunol.0903940
   PubMed Web of Science ®Google Scholar
• Boardman DA, Levings MK. Cancer immunotherapies repurposed for use in autoimmunity. Nat Biomed Eng. 2019;3:259–263. doi:10.1038/s41551-019-0359-6
   PubMed Web of Science ®Google Scholar
• Tang Q, Adams JY, Penaranda C, et al.. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity. 2008;28:687–697. doi:10.1016/j.immuni.2008.03.016
   PubMed Web of Science ®Google Scholar
• Grinberg-Bleyer Y, Baeyens A, You S, et al.. IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells. J Exp Med. 2010;207:1871–1878. doi:10.1084/jem.20100209
   PubMed Web of Science ®Google Scholar
• Trotta E, Bessette PH, Silveria SL, et al.. A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanism. Nat Med. 2018;24:1005–1014. doi:10.1038/s41591-018-0070-2
   PubMed Web of Science ®Google Scholar
• Ito S, Bollard CM, Carlsten M, et al.. Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers. Mol Ther. 2014;22:1388–1395. doi:10.1038/mt.2014.50
   PubMed Web of Science ®Google Scholar
• Winger EE, Reed JL. Low circulating CD4(+) CD25(+) Foxp3(+) T regulatory cell levels predict miscarriage risk in newly pregnant women with a history of failure. Am J Reprod Immunol. 2011;66:320–328. doi:10.1111/j.1600-0897.2011.00992.x
   PubMed Web of Science ®Google Scholar
• Mohammadi S, Abdollahi E, Nezamnia M, et al. Adoptive transfer of Tregs: a novel strategy for cell-based immunotherapy in spontaneous abortion: lessons from experimental models. Int Immunopharmacol. 2021;90:107195. doi:10.1016/j.intimp.2020.107195
   PubMed Web of Science ®Google Scholar
• Siddiqui I, Erreni M, van Brakel M, Debets R, Allavena P. Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient. J Immunother Cancer. 2016;4:21. doi:10.1186/s40425-016-0125-1
   PubMed Web of Science ®Google Scholar
• Garetto S, Sardi C, Martini E, et al.. Tailored chemokine receptor modification improves homing of adoptive therapy T cells in a spontaneous tumor model. Oncotarget. 2016;7:43010–43026. doi:10.18632/oncotarget.9280
   PubMedGoogle Scholar
• Idorn M, Skadborg SK, Kellermann L, et al.. Chemokine receptor engineering of T cells with CXCR2 improves homing towards subcutaneous human melanomas in xenograft mouse model. Oncoimmunology. 2018;7:e1450715.
   PubMed Web of Science ®Google Scholar
• Zhang L, Long X, Yin Y, et al.. Histone methyltransferase Nsd2 ensures maternal-fetal immune tolerance by promoting regulatory T-cell recruitment. Cell Mol Immunol. 2022;19:634–643. doi:10.1038/s41423-022-00849-2
   PubMed Web of Science ®Google Scholar
• Motwani K, Peters LD, Vliegen WH, et al.. Human regulatory T cells from umbilical cord blood display increased repertoire diversity and lineage stability relative to adult peripheral blood. Front Immunol. 2020;11:611. doi:10.3389/fimmu.2020.00611
   PubMed Web of Science ®Google Scholar
• Jagger A, Shimojima Y, Goronzy JJ, Weyand CM. Regulatory T cells and the immune aging process: a mini-review. Gerontology. 2014;60:130–137. doi:10.1159/000355303
   PubMed Web of Science ®Google Scholar
• Carbone F, La Rocca C, De Candia P, et al.. Metabolic control of immune tolerance in health and autoimmunity. Semin Immunol. 2016;28:491–504. doi:10.1016/j.smim.2016.09.006
   PubMed Web of Science ®Google Scholar
• Murai M, Krause P, Cheroutre H, Kronenberg M. Regulatory T-cell stability and plasticity in mucosal and systemic immune systems. Mucosal Immunol. 2010;3:443–449. doi:10.1038/mi.2010.27
   PubMed Web of Science ®Google Scholar
• Amersfoort J, Kuiper J. T cell metabolism in metabolic disease-associated autoimmunity. Immunobiology. 2017;222:925–936. doi:10.1016/j.imbio.2017.03.001
   PubMed Web of Science ®Google Scholar
• Issazadeh-Navikas S, Teimer R, Bockermann R. Influence of dietary components on regulatory T cells. Mol Med. 2012;18:95–110. doi:10.2119/molmed.2011.00311
   PubMed Web of Science ®Google Scholar
• Sharkey DJ, Tremellen KP, Briggs NE, Dekker GA, Robertson SA. Seminal plasma pro-inflammatory cytokines interferon-γ (IFNG) and C-X-C motif chemokine ligand 8 (CXCL8) fluctuate over time within men. Hum Reprod. 2017;32:1373–1381. doi:10.1093/humrep/dex106
   PubMed Web of Science ®Google Scholar
• Robertson SA, Moldenhauer LM, Green ES, Care AS, Hull ML. Immune determinants of endometrial receptivity: a biological perspective. Fertil Steril. 2022;117:1107–1120. doi:10.1016/j.fertnstert.2022.04.023
   PubMed Web of Science ®Google Scholar
• Yamazaki S, Nishioka A, Kasuya S, et al.. Homeostasis of thymus-derived Foxp3+ regulatory T cells is controlled by ultraviolet B exposure in the skin. J Immunol. 2014;193:5488–5497. doi:10.4049/jimmunol.1400985
   PubMed Web of Science ®Google Scholar
• Burzyn D, Kuswanto W, Kolodin D, et al.. A special population of regulatory T cells potentiates muscle repair. Cell. 2013;155:1282–1295. doi:10.1016/j.cell.2013.10.054
   PubMed Web of Science ®Google Scholar
• Li J, Chen Y, Liu C, Hu Y, Li L. Intravenous immunoglobulin treatment for repeated IVF/ICSI failure and unexplained infertility: a systematic review and a meta-analysis. Am J Reprod Immunol. 2013;70:434–447. doi:10.1111/aji.12170
   PubMed Web of Science ®Google Scholar
• Winger EE, Reed JL. Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion. Am J Reprod Immunol. 2008;60:8–16. doi:10.1111/j.1600-0897.2008.00585.x
   PubMed Web of Science ®Google Scholar
• Tempfer CB, Kurz C, Bentz EK, et al.. A combination treatment of prednisone, aspirin, folate, and progesterone in women with idiopathic recurrent miscarriage: a matched-pair study. Fertil Steril. 2006;86:145–148. doi:10.1016/j.fertnstert.2005.12.035
   PubMed Web of Science ®Google Scholar
• Vomstein K, Feil K, Strobel L, et al.. Immunological risk factors in recurrent pregnancy loss: guidelines versus current state of the art. J Clin Med. 2021;10:869. doi:10.3390/jcm10040869
   PubMed Web of Science ®Google Scholar
• Lee JH, Ulrich B, Cho J, Park J, Kim CH. Progesterone promotes differentiation of human cord blood fetal T cells into T regulatory cells but suppresses their differentiation into Th17 cells. J Immunol. 2011;187:1778–1787. doi:10.4049/jimmunol.1003919
   PubMed Web of Science ®Google Scholar
• Lee JH, Lydon JP, Kim CH. Progesterone suppresses the mTOR pathway and promotes generation of induced regulatory T cells with increased stability. Eur J Immunol. 2012;42:2683–2696. doi:10.1002/eji.201142317
   PubMed Web of Science ®Google Scholar
• Piccinni MP, Scaletti C, Maggi E, Romagnani S. Role of hormone-controlled Th1- and Th2-type cytokines in successful pregnancy. J Neuroimmunol. 2000;109:30–33. doi:10.1016/S0165-5728(00)00299-X
   PubMed Web of Science ®Google Scholar